Janet Woodcock

US authorizes Pfizer COVID booster for the elderly and high-risk

The United States has authorized the use of boosters of Pfizer's COVID-19 vaccine for people aged over 65, as well as adults at high risk of severe disease and those in high-exposure jobs.

The announcement means a significant part of the population, amounting to tens of millions of Americans, are now eligible for a third shot six months after their second.